2.5 |
2.5 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
2.1 |
10.6 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
2.0 |
6.0 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
1.8 |
5.3 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
1.5 |
4.6 |
GO:0097402 |
neuroblast migration(GO:0097402) |
1.2 |
4.9 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
1.2 |
3.7 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
1.1 |
1.1 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
1.1 |
10.0 |
GO:0060613 |
fat pad development(GO:0060613) |
1.1 |
3.3 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
1.0 |
5.2 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.0 |
2.1 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) |
0.9 |
9.2 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
0.9 |
3.5 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
0.8 |
0.8 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
0.8 |
2.5 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.8 |
8.3 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
0.8 |
3.3 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
0.8 |
2.4 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.8 |
2.4 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.8 |
3.1 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
0.8 |
2.3 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.8 |
4.5 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.7 |
4.4 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.7 |
5.7 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
0.7 |
3.5 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
0.7 |
2.0 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.7 |
0.7 |
GO:0032805 |
positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
0.7 |
0.7 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
0.6 |
1.9 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
0.6 |
1.9 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
0.6 |
3.8 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
0.6 |
2.5 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.6 |
2.4 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.6 |
5.3 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
0.6 |
2.3 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
0.6 |
0.6 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.5 |
0.5 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
0.5 |
1.6 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
0.5 |
1.6 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.5 |
8.1 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 |
8.6 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
0.5 |
3.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 |
1.1 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.5 |
1.0 |
GO:1902661 |
regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.5 |
0.5 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.5 |
1.5 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 |
1.5 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
0.5 |
2.0 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 |
1.5 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
0.5 |
1.9 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
0.5 |
1.4 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
0.5 |
1.4 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
0.5 |
1.4 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
0.5 |
1.4 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.5 |
0.5 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
0.5 |
1.4 |
GO:0031133 |
regulation of axon diameter(GO:0031133) intermediate filament bundle assembly(GO:0045110) |
0.5 |
4.7 |
GO:0086011 |
membrane repolarization during action potential(GO:0086011) |
0.5 |
4.2 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
0.5 |
1.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 |
0.9 |
GO:0021699 |
cerebellar cortex maturation(GO:0021699) |
0.4 |
1.3 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.4 |
4.8 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) cellular response to magnesium ion(GO:0071286) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.4 |
2.6 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
0.4 |
3.9 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
0.4 |
0.9 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 |
0.9 |
GO:0002159 |
desmosome assembly(GO:0002159) |
0.4 |
4.5 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
0.4 |
1.2 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
0.4 |
4.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 |
2.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 |
1.6 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 |
1.2 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.4 |
2.4 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
0.4 |
1.6 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
0.4 |
0.8 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
0.4 |
2.7 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 |
1.6 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
0.4 |
1.2 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
0.4 |
0.8 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.4 |
1.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 |
0.8 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.4 |
1.9 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
0.4 |
0.4 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.4 |
1.5 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
0.4 |
0.7 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 |
4.4 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
0.4 |
0.7 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 |
1.8 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 |
1.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
0.3 |
1.4 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
0.3 |
4.5 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
0.3 |
0.7 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
0.3 |
1.0 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
0.3 |
1.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
0.3 |
2.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 |
1.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 |
1.0 |
GO:0048254 |
snoRNA localization(GO:0048254) |
0.3 |
2.7 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
0.3 |
0.7 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
0.3 |
1.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 |
1.0 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) terpenoid catabolic process(GO:0016115) primary alcohol catabolic process(GO:0034310) |
0.3 |
1.7 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.3 |
4.6 |
GO:1990403 |
embryonic brain development(GO:1990403) |
0.3 |
2.0 |
GO:0014029 |
neural crest formation(GO:0014029) |
0.3 |
2.6 |
GO:0006265 |
DNA topological change(GO:0006265) |
0.3 |
1.0 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 |
1.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 |
4.5 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
0.3 |
3.5 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 |
3.8 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 |
3.8 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 |
0.6 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
0.3 |
4.9 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 |
0.9 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 |
1.5 |
GO:0001842 |
neural fold formation(GO:0001842) |
0.3 |
0.9 |
GO:0060489 |
epicardial cell to mesenchymal cell transition(GO:0003347) establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.3 |
1.2 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
0.3 |
2.1 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 |
1.4 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.3 |
1.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 |
1.7 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
0.3 |
0.3 |
GO:0060166 |
olfactory pit development(GO:0060166) |
0.3 |
1.1 |
GO:0055009 |
extraocular skeletal muscle development(GO:0002074) atrial cardiac muscle tissue development(GO:0003228) pulmonary myocardium development(GO:0003350) subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) atrial cardiac muscle tissue morphogenesis(GO:0055009) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.3 |
1.1 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 |
0.8 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 |
2.7 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 |
2.5 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
0.3 |
1.9 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
0.3 |
1.9 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
0.3 |
0.8 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
0.3 |
0.8 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
0.3 |
1.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 |
2.7 |
GO:2000288 |
positive regulation of myoblast proliferation(GO:2000288) |
0.3 |
1.3 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.3 |
0.8 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
0.3 |
1.9 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.3 |
2.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
0.3 |
0.3 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
0.3 |
0.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
0.3 |
3.7 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 |
2.1 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 |
2.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 |
0.5 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
0.3 |
1.0 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
0.2 |
0.5 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
0.2 |
0.5 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
0.2 |
1.0 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 |
1.2 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
0.2 |
1.7 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 |
2.6 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
0.2 |
2.8 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 |
2.1 |
GO:0060013 |
righting reflex(GO:0060013) |
0.2 |
7.5 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
0.2 |
0.2 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
0.2 |
2.5 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 |
0.7 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 |
0.9 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
0.2 |
1.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 |
2.2 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 |
0.4 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 |
4.6 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
0.2 |
1.1 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
0.2 |
0.9 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 |
0.9 |
GO:0046958 |
nonassociative learning(GO:0046958) |
0.2 |
1.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.2 |
0.6 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.2 |
0.9 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 |
0.8 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
0.2 |
0.6 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) regulation of osteoclast proliferation(GO:0090289) |
0.2 |
0.4 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
0.2 |
1.7 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 |
1.1 |
GO:0030091 |
protein repair(GO:0030091) |
0.2 |
0.2 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 |
0.8 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
0.2 |
0.4 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
0.2 |
1.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
0.2 |
0.6 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
0.2 |
0.8 |
GO:0003211 |
cardiac ventricle formation(GO:0003211) |
0.2 |
1.2 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
0.2 |
1.7 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
0.2 |
0.9 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 |
0.8 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
0.2 |
1.1 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
0.2 |
0.7 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.2 |
1.3 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
0.2 |
2.2 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
0.2 |
0.9 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 |
4.0 |
GO:0001709 |
cell fate determination(GO:0001709) |
0.2 |
0.5 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
0.2 |
0.9 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 |
1.1 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
0.2 |
2.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 |
1.2 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
0.2 |
0.2 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 |
1.7 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 |
0.5 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
0.2 |
0.3 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
0.2 |
1.3 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 |
0.7 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 |
0.5 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
0.2 |
1.0 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
0.2 |
0.8 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
0.2 |
0.3 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.2 |
1.8 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
0.2 |
1.0 |
GO:0032796 |
uropod organization(GO:0032796) |
0.2 |
1.1 |
GO:1901660 |
calcium ion export(GO:1901660) |
0.2 |
0.6 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
0.2 |
1.2 |
GO:0007379 |
segment specification(GO:0007379) |
0.2 |
3.1 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
0.2 |
0.3 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 |
0.8 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
0.2 |
0.6 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
0.2 |
0.6 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
0.2 |
1.1 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.2 |
1.2 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 |
0.8 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 |
0.2 |
GO:0034392 |
negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 |
1.3 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 |
0.6 |
GO:0032439 |
endosome localization(GO:0032439) |
0.1 |
0.6 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 |
0.3 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 |
0.9 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
0.1 |
0.6 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 |
0.1 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 |
0.4 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 |
0.6 |
GO:0030576 |
Cajal body organization(GO:0030576) |
0.1 |
0.9 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 |
2.4 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 |
1.0 |
GO:0071361 |
detection of calcium ion(GO:0005513) cellular response to ethanol(GO:0071361) |
0.1 |
2.1 |
GO:0003016 |
respiratory system process(GO:0003016) |
0.1 |
3.8 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
0.1 |
0.4 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
0.1 |
1.4 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
0.1 |
0.6 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.1 |
0.4 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 |
3.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
0.1 |
0.4 |
GO:0015793 |
glycerol transport(GO:0015793) |
0.1 |
0.4 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
0.1 |
1.1 |
GO:0060065 |
uterus development(GO:0060065) |
0.1 |
0.8 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 |
0.7 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 |
0.7 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.1 |
1.1 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
0.1 |
1.2 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
0.1 |
2.4 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
0.1 |
2.3 |
GO:0045116 |
protein neddylation(GO:0045116) |
0.1 |
0.8 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
0.1 |
0.3 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
0.1 |
0.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 |
0.7 |
GO:0019236 |
response to pheromone(GO:0019236) |
0.1 |
0.9 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
0.1 |
0.9 |
GO:0031000 |
response to caffeine(GO:0031000) |
0.1 |
0.5 |
GO:0071205 |
clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 |
0.7 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 |
0.4 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 |
0.8 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
0.1 |
1.5 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 |
1.1 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 |
1.0 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
0.1 |
1.4 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 |
0.7 |
GO:0050957 |
equilibrioception(GO:0050957) |
0.1 |
0.6 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 |
0.5 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.1 |
0.5 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 |
0.5 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 |
0.2 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 |
0.2 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
0.1 |
0.7 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
0.1 |
1.1 |
GO:0060736 |
prostate gland growth(GO:0060736) |
0.1 |
0.2 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
0.1 |
1.3 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 |
1.9 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
0.1 |
2.2 |
GO:0031297 |
replication fork processing(GO:0031297) |
0.1 |
5.5 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
0.1 |
1.9 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 |
0.2 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
0.1 |
1.9 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
0.1 |
0.2 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 |
0.2 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 |
1.4 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
0.1 |
1.9 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 |
1.8 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
0.1 |
1.6 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
0.1 |
0.3 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 |
1.6 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 |
0.3 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
0.1 |
0.6 |
GO:0016553 |
adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
0.1 |
0.6 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
0.1 |
0.4 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
0.1 |
0.2 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 |
0.9 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 |
0.3 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 |
0.3 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) positive regulation of mitochondrial fusion(GO:0010636) |
0.1 |
0.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
0.1 |
1.0 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
0.1 |
0.3 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
0.1 |
1.2 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
0.1 |
0.3 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 |
0.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 |
0.3 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 |
0.7 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
0.1 |
0.5 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 |
0.2 |
GO:0045472 |
response to ether(GO:0045472) |
0.1 |
0.3 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
0.1 |
0.5 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 |
0.7 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
0.1 |
2.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 |
0.7 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
0.1 |
1.6 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
0.1 |
0.4 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
0.1 |
0.9 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 |
0.3 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 |
0.1 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 |
0.2 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 |
2.8 |
GO:0048843 |
regulation of axon extension involved in axon guidance(GO:0048841) negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 |
0.1 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 |
0.9 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 |
0.5 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
0.1 |
0.3 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 |
0.8 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 |
0.9 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
0.1 |
0.3 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
0.1 |
1.2 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
0.1 |
0.5 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
0.1 |
0.4 |
GO:0018158 |
protein oxidation(GO:0018158) |
0.1 |
0.6 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
0.1 |
0.4 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
0.1 |
2.0 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
0.1 |
0.4 |
GO:0051012 |
microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.1 |
0.7 |
GO:0015074 |
DNA integration(GO:0015074) |
0.1 |
2.3 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
0.1 |
2.5 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 |
0.5 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 |
0.5 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
0.1 |
0.3 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
0.1 |
1.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
0.1 |
1.2 |
GO:0001553 |
luteinization(GO:0001553) |
0.1 |
0.3 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 |
0.3 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
0.1 |
2.7 |
GO:0035640 |
exploration behavior(GO:0035640) |
0.1 |
1.5 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 |
0.7 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
0.1 |
0.4 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
0.1 |
0.7 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 |
0.2 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
0.1 |
0.1 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.1 |
2.0 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
0.1 |
0.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
0.1 |
0.9 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 |
0.2 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
0.1 |
0.8 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 |
2.7 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
0.1 |
0.6 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
0.1 |
0.4 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 |
0.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 |
1.1 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 |
0.6 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 |
0.4 |
GO:0007296 |
vitellogenesis(GO:0007296) |
0.1 |
0.3 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 |
0.5 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 |
1.2 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
0.1 |
1.2 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
0.1 |
0.2 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
0.1 |
0.4 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 |
0.6 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
0.1 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
0.1 |
0.8 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.1 |
0.2 |
GO:0045176 |
apical protein localization(GO:0045176) |
0.1 |
0.4 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
0.1 |
0.7 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 |
0.3 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 |
0.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
0.1 |
1.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
0.1 |
0.5 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
0.1 |
1.1 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
0.1 |
0.4 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 |
0.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
0.1 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
0.1 |
1.5 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
0.1 |
0.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 |
0.4 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 |
2.7 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 |
0.6 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
0.1 |
0.3 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 |
0.3 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 |
0.3 |
GO:0032899 |
regulation of neurotrophin production(GO:0032899) positive regulation of neurotrophin production(GO:0032901) |
0.1 |
0.2 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
0.1 |
1.2 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
0.1 |
2.3 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
0.1 |
0.4 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.1 |
0.1 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 |
1.2 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 |
0.1 |
GO:0098910 |
regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.1 |
0.1 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 |
0.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 |
0.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 |
0.3 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 |
8.7 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 |
0.8 |
GO:2000785 |
regulation of vacuole organization(GO:0044088) regulation of autophagosome assembly(GO:2000785) |
0.1 |
0.1 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 |
0.1 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
0.1 |
0.3 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
0.1 |
0.1 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) protein secretion by platelet(GO:0070560) |
0.1 |
0.4 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
0.1 |
0.2 |
GO:0035087 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 |
0.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 |
0.2 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
0.1 |
0.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 |
0.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
0.1 |
0.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 |
0.5 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 |
0.8 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
0.0 |
0.2 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
0.0 |
1.5 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 |
0.5 |
GO:0001960 |
negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 |
0.9 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
0.0 |
0.2 |
GO:0031424 |
keratinization(GO:0031424) |
0.0 |
0.2 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) serine phosphorylation of STAT protein(GO:0042501) |
0.0 |
0.2 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
0.0 |
0.5 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
0.0 |
0.2 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
0.0 |
0.6 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 |
0.6 |
GO:2000352 |
negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 |
0.1 |
GO:0090399 |
replicative senescence(GO:0090399) |
0.0 |
0.7 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
0.0 |
18.6 |
GO:0006397 |
mRNA processing(GO:0006397) |
0.0 |
0.4 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
0.0 |
0.1 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
0.0 |
0.4 |
GO:0016926 |
protein desumoylation(GO:0016926) |
0.0 |
0.4 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 |
0.1 |
GO:0086012 |
membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.0 |
0.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
0.0 |
0.2 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
0.0 |
0.3 |
GO:0006497 |
protein lipidation(GO:0006497) lipoprotein biosynthetic process(GO:0042158) |
0.0 |
0.9 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
0.0 |
0.5 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
0.0 |
1.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
0.0 |
0.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 |
0.2 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
0.0 |
0.2 |
GO:1903056 |
melanocyte migration(GO:0097324) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
0.0 |
0.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
0.0 |
0.1 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
0.0 |
0.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
0.0 |
0.3 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 |
0.8 |
GO:0016180 |
snRNA processing(GO:0016180) |
0.0 |
0.8 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
0.0 |
0.6 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 |
2.1 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
0.0 |
0.4 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 |
0.5 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 |
0.9 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
0.0 |
0.1 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 |
0.1 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 |
0.1 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 |
0.2 |
GO:0030238 |
male sex determination(GO:0030238) |
0.0 |
0.1 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
0.0 |
0.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 |
0.1 |
GO:0070633 |
transepithelial transport(GO:0070633) |
0.0 |
0.2 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 |
0.5 |
GO:0006828 |
manganese ion transport(GO:0006828) |
0.0 |
0.1 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
0.0 |
3.8 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
0.0 |
2.1 |
GO:0006096 |
glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.0 |
0.1 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
0.0 |
0.0 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
0.0 |
0.2 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
0.0 |
0.1 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.0 |
0.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
0.0 |
1.0 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
0.0 |
1.4 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
0.0 |
0.2 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
0.0 |
0.5 |
GO:0065005 |
protein-lipid complex assembly(GO:0065005) |
0.0 |
0.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
0.0 |
1.1 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 |
0.4 |
GO:0050892 |
intestinal absorption(GO:0050892) |
0.0 |
0.0 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 |
0.1 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
0.0 |
0.1 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 |
0.2 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
0.0 |
0.2 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 |
0.2 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 |
0.6 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
0.0 |
0.1 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
0.0 |
0.1 |
GO:0034351 |
negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 |
0.5 |
GO:0001947 |
heart looping(GO:0001947) |
0.0 |
0.7 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
0.0 |
1.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
0.0 |
0.1 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 |
0.3 |
GO:0090102 |
cochlea development(GO:0090102) |
0.0 |
1.4 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 |
0.2 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
0.0 |
1.2 |
GO:0032204 |
regulation of telomere maintenance(GO:0032204) |
0.0 |
0.6 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
0.0 |
0.1 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
0.0 |
0.3 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
0.0 |
0.4 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
0.0 |
0.2 |
GO:0060546 |
negative regulation of necroptotic process(GO:0060546) |
0.0 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
0.0 |
0.0 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 |
1.7 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
0.0 |
0.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 |
0.2 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 |
0.1 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
0.0 |
0.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
0.0 |
0.2 |
GO:0007143 |
female meiotic division(GO:0007143) |
0.0 |
0.1 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.0 |
0.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
0.0 |
0.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 |
0.0 |
GO:0060295 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 |
0.1 |
GO:2000810 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) regulation of bicellular tight junction assembly(GO:2000810) |
0.0 |
0.1 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
0.0 |
0.1 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
0.0 |
0.9 |
GO:0051028 |
mRNA transport(GO:0051028) |
0.0 |
0.5 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
0.0 |
0.1 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 |
0.1 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 |
0.1 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.0 |
0.3 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
0.0 |
0.1 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
0.0 |
0.0 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.0 |
0.2 |
GO:0048240 |
sperm capacitation(GO:0048240) |
0.0 |
0.8 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
0.0 |
0.5 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
0.0 |
0.4 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
0.0 |
0.3 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 |
0.4 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
0.0 |
0.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
0.0 |
0.4 |
GO:0006284 |
base-excision repair(GO:0006284) |
0.0 |
0.4 |
GO:0051298 |
centrosome duplication(GO:0051298) |
0.0 |
0.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
0.0 |
0.7 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
0.0 |
0.3 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
0.0 |
0.1 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
0.0 |
0.2 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |